Catherine Pachuk
Chief Tech/Sci/R&D Officer bij MARIZYME, INC.
Vermogen: 20 153 $ op 31-03-2024
Profiel
Catherine J.
Pachuk is the founder of Nucleonics, Inc. founded in 2001.
Currently, she holds the position of Director & Chief Scientific Officer at Somahlution LLC since 2011 and Chief Science Officer at Marizyme, Inc. since 2020.
Dr. Pachuk holds a doctorate degree from the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MARIZYME INCORPORATED
0.58% | 20-06-2023 | 268 710 ( 0.58% ) | 20 153 $ | 31-03-2024 |
Actieve functies van Catherine Pachuk
| Bedrijven | Functie | Begin |
|---|---|---|
| MARIZYME, INC. | Chief Tech/Sci/R&D Officer | - |
Somahlution LLC
 Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Chief Tech/Sci/R&D Officer | 01-08-2011 |
Eerdere bekende functies van Catherine Pachuk
| Bedrijven | Functie | Einde |
|---|---|---|
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Founder | - |
Opleiding van Catherine Pachuk
| University of Pennsylvania | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MARIZYME, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Distribution Services |
